Answers are grounded in this paper and cite their sources.
The influenza virus neuraminidase is an emerging target for universal influenza virus vaccines. However, in contrast to influenza virus hemagglutinin, we know little about antibody epitopes and antigenic sites on the neuraminidase. Characterizing and defining these sites is aiding vaccine development and helping to understand antigenic drift of NA.
No takes yet. Share an insight, caveat, or question.
Roubidoux et al. (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: